Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model
Authors
Keywords
-
Journal
OncoImmunology
Volume 6, Issue 8, Pages e1338236
Publisher
Informa UK Limited
Online
2017-06-16
DOI
10.1080/2162402x.2017.1338236
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel rat fibrosarcoma cell line from transformed bone marrow-derived mesenchymal stem cells with maintained in vitro and in vivo stemness properties
- (2017) Meng-Yu Wang et al. EXPERIMENTAL CELL RESEARCH
- LTX-315, CAPtivating immunity with necrosis
- (2016) Antonella Sistigu et al. CELL CYCLE
- The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade
- (2016) T Yamazaki et al. CELL DEATH AND DIFFERENTIATION
- Can immunostimulatory agents enhance the abscopal effect of radiotherapy?
- (2016) Antonin Levy et al. EUROPEAN JOURNAL OF CANCER
- Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide
- (2016) Bengt Erik Haug et al. JOURNAL OF MEDICINAL CHEMISTRY
- The oncolytic peptide LTX-315 triggers immunogenic cell death
- (2016) H Zhou et al. Cell Death & Disease
- Can abscopal effects of local radiotherapy be predicted by modeling T cell trafficking?
- (2016) Sandra Demaria et al. Journal for ImmunoTherapy of Cancer
- The oncolytic peptide LTX-315 triggers necrotic cell death
- (2015) Sabrina Forveille et al. CELL CYCLE
- Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches
- (2015) Qin Pan et al. STEM CELLS
- The oncolytic peptide LTX-315 kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization
- (2015) Heng Zhou et al. Oncotarget
- Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
- (2015) Bin Shang et al. Scientific Reports
- Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315
- (2014) Ketil André Camilio et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- LTX-315 (Oncopore™)
- (2014) Ketil André Camilio et al. OncoImmunology
- Consensus guidelines for the detection of immunogenic cell death
- (2014) Oliver Kepp et al. OncoImmunology
- Cancer Stem Cells and Their Mechanism of Chemo-Radiation Resistance
- (2014) Yonghyun Kim et al. International Journal of Stem Cells
- Understanding and targeting cancer stem cells: therapeutic implications and challenges
- (2013) Ke Chen et al. ACTA PHARMACOLOGICA SINICA
- Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
- (2013) Jérôme Galon et al. JOURNAL OF PATHOLOGY
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- From antimicrobial to anticancer peptides. A review
- (2013) Diana Gaspar et al. Frontiers in Microbiology
- Toward integrative cancer immunotherapy: targeting the tumor microenvironment
- (2012) Leisha A Emens et al. Journal of Translational Medicine
- The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
- (2011) M J M Gooden et al. BRITISH JOURNAL OF CANCER
- Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
- (2011) Peter Friedl et al. CELL
- TNM Staging in Colorectal Cancer: T Is for T Cell and M Is for Memory
- (2011) Elizabeth K. Broussard et al. JOURNAL OF CLINICAL ONCOLOGY
- On the selectivity and efficacy of defense peptides with respect to cancer cells
- (2011) Frederick Harris et al. MEDICINAL RESEARCH REVIEWS
- Cationic amphiphilic peptides with cancer-selective toxicity
- (2009) Frank Schweizer EUROPEAN JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started